Curi RMB Capital LLC Has $10.90 Million Holdings in IQVIA Holdings Inc. (NYSE:IQV)

Curi RMB Capital LLC decreased its position in shares of IQVIA Holdings Inc. (NYSE:IQV - Free Report) by 15.0% during the third quarter, according to its most recent filing with the SEC. The firm owned 45,978 shares of the medical research company's stock after selling 8,098 shares during the period. Curi RMB Capital LLC's holdings in IQVIA were worth $10,895,000 at the end of the most recent quarter.

A number of other institutional investors have also added to or reduced their stakes in IQV. First Foundation Advisors increased its stake in shares of IQVIA by 3.8% in the second quarter. First Foundation Advisors now owns 1,161 shares of the medical research company's stock worth $245,000 after purchasing an additional 43 shares in the last quarter. Invera Wealth Advisors LLC raised its position in IQVIA by 0.3% during the 2nd quarter. Invera Wealth Advisors LLC now owns 14,506 shares of the medical research company's stock valued at $3,183,000 after purchasing an additional 46 shares in the last quarter. Covestor Ltd increased its position in IQVIA by 45.3% during the 1st quarter. Covestor Ltd now owns 154 shares of the medical research company's stock valued at $39,000 after purchasing an additional 48 shares during the period. Oregon Public Employees Retirement Fund raised its stake in IQVIA by 0.3% in the second quarter. Oregon Public Employees Retirement Fund now owns 15,668 shares of the medical research company's stock worth $3,313,000 after buying an additional 48 shares in the last quarter. Finally, Continuum Advisory LLC raised its position in shares of IQVIA by 3.3% in the 2nd quarter. Continuum Advisory LLC now owns 1,538 shares of the medical research company's stock worth $325,000 after acquiring an additional 49 shares in the last quarter. Institutional investors own 89.62% of the company's stock.

IQVIA Stock Performance

NYSE:IQV traded down $10.31 during mid-day trading on Friday, hitting $192.63. The stock had a trading volume of 4,579,132 shares, compared to its average volume of 1,143,450. IQVIA Holdings Inc. has a 52 week low of $189.63 and a 52 week high of $261.73. The stock has a market capitalization of $34.96 billion, a price-to-earnings ratio of 25.62, a P/E/G ratio of 2.17 and a beta of 1.51. The company has a 50 day simple moving average of $227.96 and a 200-day simple moving average of $228.59. The company has a current ratio of 0.81, a quick ratio of 0.81 and a debt-to-equity ratio of 1.76.

Analyst Upgrades and Downgrades

A number of research firms have commented on IQV. StockNews.com cut IQVIA from a "buy" rating to a "hold" rating in a research note on Friday, November 8th. Barclays reduced their price objective on IQVIA from $260.00 to $255.00 and set an "overweight" rating for the company in a research note on Friday, November 1st. The Goldman Sachs Group decreased their price objective on shares of IQVIA from $280.00 to $250.00 and set a "buy" rating for the company in a research report on Friday, November 1st. Evercore ISI reduced their price objective on shares of IQVIA from $270.00 to $265.00 and set an "outperform" rating for the company in a research report on Tuesday, October 8th. Finally, Redburn Atlantic started coverage on IQVIA in a report on Monday, October 14th. They issued a "buy" rating and a $276.00 price objective on the stock. Five equities research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat, IQVIA has an average rating of "Moderate Buy" and a consensus target price of $259.13.

Insider Transactions at IQVIA

In other news, insider Eric Sherbet sold 1,300 shares of the business's stock in a transaction on Tuesday, August 27th. The shares were sold at an average price of $246.33, for a total transaction of $320,229.00. Following the transaction, the insider now directly owns 19,536 shares in the company, valued at $4,812,302.88. The trade was a 6.24 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Corporate insiders own 1.60% of the company's stock.

IQVIA Profile

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.